Kalaris Therapeutics, Inc. (KLRS)
Market Closed
26 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (CM) Primary NASDAQ (NMS) $
1. 80
-0.07
-3.7433%
After Hours
$
+0.2 +11.1111% 2. 00
87.9M Market Cap
- P/E Ratio
- Div Yield
36,033 Volume
-1.75 Eps
$ 1.87
Previous Close Investors:
Want to track KLRS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kalaris Therapeutics, Inc. (KLRS) Statistics
Valuation metrics
Market Cap 87.9M
Enterprise value -931.77K
Trailing P/E (ttm) -0.93
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.77
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.02
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 76.56K
Average volume (90 days) 72.16K
Price summary
52-Week low 1.78
52-Week high 11.88
Beta -
50-Day moving average 2.77
200-Day moving average 4.22
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:23
Last split Date 16 Jan 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.44%
Return on equity -0.72%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.86
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.93
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 10.98%
Book value per share (mrq) 2.42
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
